Хайлтын үр дүнгүүд - Ruth Perets
- 13-н 1 - 13 үр дүнгүүдийг харуулж байна
-
1
-
2
-
3
An open-label, multicenter Phase 1b study of radium-223 + paclitaxel in cancer patients with bone metastases -н Ravit Geva, Juanita Lopez, Sarah Danson, Heikki Joensuu, A. Peer, S.J. Harris, Fabrício Henrique Pereira De Souza, Bart A. Ploeger, K.M.C. Pereira, Ruth Perets
Хэвлэсэн 2017Artigo -
4
The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies -н Ronnie Shapira-Frommer, Jiaxin Niu, Ruth Perets, Solange Peters, Geoffrey Shouse, Iwona Ługowska, Marina Chiara Garassino, Jacob Sands, Tanya E. Keenan, Bin Zhao, Jane Healy, Myung‐Ju Ahn
Хэвлэсэн 2024Artigo -
5
Safety of Radium-223 + Paclitaxel in Cancer Patients with Bone Metastases: Results from an Open-Label, Multicenter Phase 1b Study -н Richard K. Valicenti, Ruth Perets, Juanita Lopez, Sarah Danson, Heikki Joensuu, A. Peer, S.J. Harris, Fabrício Henrique Pereira De Souza, Bart A. Ploeger, K.M.C. Pereira, Ravit Geva
Хэвлэсэн 2017Artigo -
6
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study -н Hyun Cheol Chung, Willeke Ros, Jean‐Pierre Delord, Ruth Perets, Antoîne Italiano, Ronnie Shapira‐Frommer, Lyudmila Manzuk, Sarina A. Piha‐Paul, Lei Xu, Susan Zeigenfuss, Scott K. Pruitt, Alexandra Léary
Хэвлэсэн 2019Artigo -
7
First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors -н Lillian L. Siu, Ding Wang, John Hilton, Ravit Geva, Drew Rasco, Ruth Perets, Anson K. Abraham, Douglas C. Wilson, Julia F. Markensohn, Jared Lunceford, Leah Suttner, Shabana Siddiqi, Rachel A. Altura, Corinne Maurice‐Dror
Хэвлэсэн 2021Carta -
8
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models -н Ruth Perets, Gregory A. Wyant, Katherine W. Muto, Jonathan G. Bijron, Barish B. Poole, Kenneth T. Chin, Jin Yun Chen, Anders Öhman, Corey D. Stepule, Soongu Kwak, Alison M. Karst, Michelle S. Hirsch, Sunita R. Setlur, Christopher P. Crum, Daniela M. Dinulescu, Ronny Drapkin
Хэвлэсэн 2013Artigo -
9
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment -н Eleni Maniati, Chiara Berlato, Ganga Gopinathan, Owen Heath, Panoraia Kotantaki, Anissa Lakhani, Jacqueline McDermott, Colin Pegrum, Robin M. Delaine‐Smith, Oliver M.T. Pearce, Priyanka Hirani, Joash D. Joy, Ludmila Szabova, Ruth Perets, Owen J. Sansom, Ronny Drapkin, Peter J. Bailey, Frances R. Balkwill
Хэвлэсэн 2020Artigo -
10
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer -н Ruth Perets, Jair Bar, Drew Rasco, Myung‐Ju Ahn, Kiyotaka Yoh, D.-W. Kim, Adnan Nagrial, Miyako Satouchi, Daniel Lee, David R. Spigel, Dusan Kotasek, Martin Gutierrez, Jiaxin Niu, Shabana Siddiqi, X. Li, Jobin Cyrus, Alissa A. Chackerian, Anne Chain, Rachel A. Altura, Byoung Chul Cho
Хэвлэсэн 2020Artigo -
11
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts -н Mark A. Eckert, Fabian Coscia, Agnieszka Chryplewicz, Jae Won Chang, Kyle M. Hernandez, Shawn Pan, Samantha M. Tienda, Dominik A. Nahotko, Gang Li, Ivana Blaženović, Ricardo R. Lastra, Marion Curtis, S. Diane Yamada, Ruth Perets, Stephanie M. McGregor, Jorge Andrade, Oliver Fiehn, Raymond E. Moellering, Matthias Mann, Ernst Lengyel
Хэвлэсэн 2019Artigo -
12
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy -н Toni K. Choueiri, Harriet M. Kluger, Saby George, Scott S. Tykodi, Timothy M. Kuzel, Ruth Perets, Suresh Nair, Giuseppe Procopio, Michael A. Carducci, Vincent Castonguay, Edmund Folefac, Chung‐Han Lee, Sébastien J. Hotte, Wilson H. Miller, Shruti Shally Saggi, Chung‐Wei Lee, Heshani Desilva, Prabhu Bhagavatheeswaran, Robert J. Motzer, Bernard Escudier
Хэвлэсэн 2022Artigo -
13
PRKCI promotes immune suppression in ovarian cancer -н Sharmistha Sarkar, Christopher A. Bristow, Prasenjit Dey, Kunal Rai, Ruth Perets, Alejandra Ramirez‐Cardenas, Shruti Malasi, Emmet Huang-Hobbs, Monika Haemmerle, Sherry Y. Wu, Michael H. McGuire, Alexei Protopopov, Shan Jiang, Joyce F. Liu, Michelle S. Hirsch, Qing Chang, Alexander J. Lazar, Anil K. Sood, Ronny Drapkin, Ronald A. DePinho, Giulio Draetta, Lynda Chin
Хэвлэсэн 2017Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Cancer
Internal medicine
Medicine
Oncology
Cancer research
Biology
Immunotherapy
Biochemistry
Chemotherapy
Clinical trial
Gene
Immunology
Ovarian cancer
Pembrolizumab
Genetics
Gynecology
Serous fluid
Adverse effect
Antibody
Cell biology
Clinical endpoint
Combination therapy
Concomitant
Fallopian tube
Febrile neutropenia
Gastroenterology
Neutropenia
Ovarian carcinoma
Phases of clinical research
Surgery